45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,240
Insurances with rates
40
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 397 | APPENDIX PROCEDURES WITH MCC | $57,679 | $37,491 | — | — | 59 |
| 094 | BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITH MCC | $48,505 | $31,528 | — | — | 44 |
| 348 | ANAL AND STOMAL PROCEDURES WITH CC | $42,320 | $27,508 | — | — | 59 |
| RX-195988 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $40,882 | $26,573 | — | — | 116 |
| RX-191027 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION|RX AMT DISCARD/NOT ADMIN TO PT | $37,980 | $24,687 | — | — | 116 |
| RX-218713 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION|RX AMT DISCARD/NOT ADMIN TO PT | $37,694 | $24,501 | — | — | 116 |
| 896 | ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC | $36,635 | $23,813 | — | — | 59 |
| RX-227274 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION|RX AMT DISCARD/NOT ADMIN TO PT | $35,533 | $23,096 | — | — | 116 |
| 398 | APPENDIX PROCEDURES WITH CC | $34,197 | $22,228 | — | — | 59 |
| 281 | ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH CC | $32,153 | $20,900 | — | — | 59 |
| 308 | CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MCC | $29,091 | $18,909 | — | — | 65 |
| 303 | ATHEROSCLEROSIS WITHOUT MCC | $28,925 | $18,801 | — | — | 65 |
| 202 | BRONCHITIS AND ASTHMA WITH CC/MCC | $27,174 | $17,663 | — | — | 65 |
| 302 | ATHEROSCLEROSIS WITH MCC | $27,022 | $17,564 | — | — | 65 |
| RX-79826 | ALTEPLASE 100 MG INTRAVENOUS SOLUTION | $26,489 | $17,218 | — | — | 116 |
| RX-229308 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION | $26,398 | $17,158 | — | — | 116 |
| SUP-CAP1117 | CAP SHOULDER SYSTEM REV ASCEND FLX BASEPLATE CAP1117 | $26,100 | $16,965 | — | — | 79 |
| 309 | CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH CC | $22,874 | $14,868 | — | — | 65 |
| 399 | APPENDIX PROCEDURES WITHOUT CC/MCC | $21,822 | $14,185 | — | — | 65 |
| RX-204465 | ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION | $21,396 | $13,908 | — | — | 116 |
| 603 | CELLULITIS WITHOUT MCC | $20,504 | $13,328 | — | — | 65 |
| SUP-PS41002 | ALLOGRAFT CARTIFORM CHONDRAL 20MM PS41002 | $19,125 | $12,431 | — | — | 79 |
| SUP-ABS-1101-20 | ALLOGRAFT CARTIFORM DISC 20MM ABS-1101-20 | $19,125 | $12,431 | — | — | 79 |
| 602 | CELLULITIS WITH MCC | $18,996 | $12,347 | — | — | 65 |
| 897 | ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC | $17,978 | $11,686 | — | — | 64 |
| SUP-150443 | AUGMENT TIB OSS 20X79/83 150443 | $15,566 | $10,118 | — | — | 79 |
| 310 | CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT CC/MCC | $15,500 | $10,075 | — | — | 65 |
| 894 | ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA | $14,736 | $9,579 | — | — | 65 |
| SUP-ABS-1102-19 | ALLOGRAFT CARTIFORM 19X12MM ABS-1102-19 | $14,063 | $9,141 | — | — | 79 |
| RX-204464 | ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION | $13,377 | $8,695 | — | — | 116 |
| RX-79456 | ALTEPLASE 50 MG INTRAVENOUS SOLUTION | $13,245 | $8,609 | — | — | 116 |
| PX-100000019 | Bone Marrow Bx Ndl/Trocar | $11,106 | $7,219 | — | — | 73 |
| 203 | BRONCHITIS AND ASTHMA WITHOUT CC/MCC | $10,939 | $7,111 | — | — | 65 |
| RX-89931 | BEVACIZUMAB 25 MG/ML INTRAVENOUS SOLUTION | $10,691 | $6,949 | — | — | 232 |
| SUP-211229 | AUGMENT CMPRHNSV SRS MOD RGNRX LG 211229 | $10,418 | $6,772 | — | — | 79 |
| SUP-211228 | AUGMENT CMPRHNSV SRS MOD RGNRX SM 211228 | $10,418 | $6,772 | — | — | 79 |
| CASE-38500 | Bx/Exc Lymph Node Open Superficial | $10,160 | $6,604 | — | — | 55 |
| RX-178388 | BENDAMUSTINE 100 MG INTRAVENOUS POWDER FOR SOLUTION | $9,968 | $6,479 | — | — | 116 |
| SUP-ABS-4200-038 | ALLOGRAFT AMINION 3X8CM THICK ABS-4200-038 | $9,900 | $6,435 | — | — | 79 |
| CASE-56605 | Biopsy of Perineum | $9,886 | $6,426 | — | — | 52 |
| CASE-56606 | Biopsy Vulva/Perineum Each Addl Lesion | $9,886 | $6,426 | — | — | 52 |
| RX-241472 | BEVACIZUMAB-MALY 25 MG/ML INTRAVENOUS SOLUTION | $9,641 | $6,267 | — | — | 232 |
| RX-230292 | BEVACIZUMAB-AWWB 25 MG/ML INTRAVENOUS SOLUTION | $9,362 | $6,085 | — | — | 232 |
| SUP-6276-3-005 | BODY BROACHED #5 6276-3-005 | $9,171 | $5,961 | — | — | 79 |
| RX-243685 | BEVACIZUMAB-ADCD 25 MG/ML INTRAVENOUS SOLUTION | $9,089 | $5,908 | — | — | 232 |
| SUP-1506-60-004 | BASEPLATE TIB ATTUNE REV SZ4 1506-60-004 | $8,688 | $5,647 | — | — | 79 |
| SUP-1506-60-005 | BASEPLATE TIB ATTUNE REV SZ5 1506-60-005 | $8,688 | $5,647 | — | — | 79 |
| SUP-1506-60-006 | BASEPLATE TIB ATTUNE REV SZ6 1506-60-006 | $8,688 | $5,647 | — | — | 79 |
| SUP-1506-60-008 | BASEPLATE TIB ATTUNE REV SZ8 1506-60-008 | $8,688 | $5,647 | — | — | 79 |
| SUP-4920-9-810 | ANKLE KT HOFFMAN II 4920-9-810 | $8,401 | $5,461 | — | — | 79 |
Showing top 50 of 2,240 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.